Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Maryam B. Lustberg, Nicole M. Kuderer, Aakash Desai, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 527-542
Open Access | Times Cited: 106
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 97
The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies
Kantarakorn Unchiti, Prangmalee Leurcharusmee, Artid Samerchua, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 9, pp. 7006-7047
Closed Access | Times Cited: 56
Toxic effects of cancer therapies
Shweta Ingole, Nupur Vasdev, Muktika Tekade, et al.
Elsevier eBooks (2024), pp. 353-379
Closed Access | Times Cited: 10
Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
Effects of Baduanjin exercise on cognitive function and cancer-related symptoms in women with breast cancer receiving chemotherapy: a randomized controlled trial
Xiaolin Wei, Ruzhen Yuan, Juan Yang, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 7, pp. 6079-6091
Open Access | Times Cited: 33
Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
Mary H. Samuels, Lori J. Bernstein
Thyroid (2022) Vol. 32, Iss. 7, pp. 752-763
Open Access | Times Cited: 28
Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models
Kamilia M. Ibrahim, Samar F. Darwish, Eman M. Mantawy, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1873-1893
Open Access | Times Cited: 18
Endothelial TFEB signaling-mediated autophagic disturbance initiates microglial activation and cognitive dysfunction
Ya-Ping Lu, Xiang Chen, Xiuxiu Liu, et al.
Autophagy (2023) Vol. 19, Iss. 6, pp. 1803-1820
Open Access | Times Cited: 16
Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: Imperative roles of AMPK/Akt/CREB/ BDNF signaling cascades
Abdulla M.A. Mahmoud, Eman M. Mantawy, Sara A. Wahdan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114238-114238
Open Access | Times Cited: 16
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Fabio Ntagwabira, Madison Trujillo, Taylor McElroy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2008-2008
Open Access | Times Cited: 23
Phytochemical profiling and neuroprotective activity of Callistemon subulatus leaves against cyclophosphamide-induced chemobrain
Omyma Rabie, Heba A. S. El‐Nashar, Mina Y. George, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115596-115596
Open Access | Times Cited: 14
Captopril attenuates oxidative stress and neuroinflammation implicated in cisplatin-induced cognitive deficits in rats
Fatma Mostafa, Eman M. Mantawy, Riham S. Said, et al.
Psychopharmacology (2025)
Open Access
Glioblastoma’s Infrequent Locations and Synchronous Tumors
Asem A. Muhsen, Baha’eddin A. Muhsen
IntechOpen eBooks (2025)
Closed Access
The chemotherapy agent doxorubicin induces CNS expression of Ascl1, a regulator of adult neurogenesis and differentiation
Christi Anne S. Ng, Morgan Pedus, Madeline F. Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy
Jac A. Nickoloff, Lynn E. Taylor, Neelam Sharma, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 31
Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
Omar Cauli
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1116-1116
Open Access | Times Cited: 31
Self-Reported Assessment of the Socio-Economic Impact of Anticancer Chemotherapy-Related Neurotoxicity
Guido Cavaletti, Alessia D’Acunti, Alessandro Porcu, et al.
Toxics (2023) Vol. 11, Iss. 2, pp. 104-104
Open Access | Times Cited: 12
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: A Qualitative Systematic Review (Preprint)
Maryam Ibrar, Harleen Kaur, Ashleigh Main, et al.
(2025)
Closed Access
Chemotherapy-related cognitive impairment and kidney dysfunction
Mariadelina Simeoni, Michele M. Mulholland, Biruh Workeneh, et al.
Nephrology Dialysis Transplantation (2025) Vol. 40, Iss. Supplement_2, pp. ii54-ii63
Open Access
Meta-analyses of executive function deficits in chemotherapy-treated rodent models
Weiye Chen, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2025), pp. 106131-106131
Open Access
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
Avallone Antonio, Sabrina Bimonte, Claudia Cardone, et al.
Anticancer Research (2022) Vol. 42, Iss. 10, pp. 4667-4678
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top